Moderna-backed Metagenomi sees stock fall 31% after $94M IPO (NASDAQ:MGX)
2d illustrations and photos/iStock via Getty Images Moderna-backed Metagenomi Technologies (NASDAQ:MGX) stock was down 31% Friday afternoon in the wake of a $94M initial public offering that priced at the low-end of its previously…
